Cargando…

Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa

In most sub-Saharan countries screening of blood-transmitted infections includes mainly HIV, HBV, HCV and syphilis. Many viruses such as Hepatitis G (HGV) and Epstein-Barr virus (EBV) which also carry a risk of transmission by blood transfusion raise the question of the extent of screening for these...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Issoufou, Bisseye, Cyrille, Nagalo, Bolni Marius, Sanou, Mahamoudou, Kiba, Alice, Surat, Guzin, Compaoré, Tegwindé Rebeca, Traoré, Lassina, Nikiema, Jean Baptiste, Pietra, Virginio, Zongo, Jean-Didier, Simpore, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787664/
https://www.ncbi.nlm.nih.gov/pubmed/24106603
http://dx.doi.org/10.4084/MJHID.2013.053
_version_ 1782286216349089792
author Tao, Issoufou
Bisseye, Cyrille
Nagalo, Bolni Marius
Sanou, Mahamoudou
Kiba, Alice
Surat, Guzin
Compaoré, Tegwindé Rebeca
Traoré, Lassina
Nikiema, Jean Baptiste
Pietra, Virginio
Zongo, Jean-Didier
Simpore, Jacques
author_facet Tao, Issoufou
Bisseye, Cyrille
Nagalo, Bolni Marius
Sanou, Mahamoudou
Kiba, Alice
Surat, Guzin
Compaoré, Tegwindé Rebeca
Traoré, Lassina
Nikiema, Jean Baptiste
Pietra, Virginio
Zongo, Jean-Didier
Simpore, Jacques
author_sort Tao, Issoufou
collection PubMed
description In most sub-Saharan countries screening of blood-transmitted infections includes mainly HIV, HBV, HCV and syphilis. Many viruses such as Hepatitis G (HGV) and Epstein-Barr virus (EBV) which also carry a risk of transmission by blood transfusion raise the question of the extent of screening for these pathogens. This work aims to evaluate the prevalence of HGV and EBV in first-time blood donors in Ouagadougou. The prevalence of HGV and EBV in 551 blood donors was 7.4% and 5.4% respectively. HGV prevalence was significantly higher in blood donors with hepatitis B antigens and positive for HCV compared to donors negative for HCV and no hepatitis B antigens (respectively p<0.001 and p=0.004). EBV prevalence was higher among blood donors of < 20 years age group. HBV and HCV positive individuals are not eligible for blood donation. This study shows significant results with regard to the prevalence of HGV and EBV prevalence in blood donors in Burkina Faso and emphasizes the need for a general screening.
format Online
Article
Text
id pubmed-3787664
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-37876642013-10-08 Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa Tao, Issoufou Bisseye, Cyrille Nagalo, Bolni Marius Sanou, Mahamoudou Kiba, Alice Surat, Guzin Compaoré, Tegwindé Rebeca Traoré, Lassina Nikiema, Jean Baptiste Pietra, Virginio Zongo, Jean-Didier Simpore, Jacques Mediterr J Hematol Infect Dis Original Article In most sub-Saharan countries screening of blood-transmitted infections includes mainly HIV, HBV, HCV and syphilis. Many viruses such as Hepatitis G (HGV) and Epstein-Barr virus (EBV) which also carry a risk of transmission by blood transfusion raise the question of the extent of screening for these pathogens. This work aims to evaluate the prevalence of HGV and EBV in first-time blood donors in Ouagadougou. The prevalence of HGV and EBV in 551 blood donors was 7.4% and 5.4% respectively. HGV prevalence was significantly higher in blood donors with hepatitis B antigens and positive for HCV compared to donors negative for HCV and no hepatitis B antigens (respectively p<0.001 and p=0.004). EBV prevalence was higher among blood donors of < 20 years age group. HBV and HCV positive individuals are not eligible for blood donation. This study shows significant results with regard to the prevalence of HGV and EBV prevalence in blood donors in Burkina Faso and emphasizes the need for a general screening. Università Cattolica del Sacro Cuore 2013-09-02 /pmc/articles/PMC3787664/ /pubmed/24106603 http://dx.doi.org/10.4084/MJHID.2013.053 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Tao, Issoufou
Bisseye, Cyrille
Nagalo, Bolni Marius
Sanou, Mahamoudou
Kiba, Alice
Surat, Guzin
Compaoré, Tegwindé Rebeca
Traoré, Lassina
Nikiema, Jean Baptiste
Pietra, Virginio
Zongo, Jean-Didier
Simpore, Jacques
Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa
title Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa
title_full Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa
title_fullStr Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa
title_full_unstemmed Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa
title_short Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa
title_sort screening of hepatitis g and epstein-barr viruses among voluntary non remunerated blood donors (vnrbd) in burkina faso, west africa
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787664/
https://www.ncbi.nlm.nih.gov/pubmed/24106603
http://dx.doi.org/10.4084/MJHID.2013.053
work_keys_str_mv AT taoissoufou screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica
AT bisseyecyrille screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica
AT nagalobolnimarius screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica
AT sanoumahamoudou screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica
AT kibaalice screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica
AT suratguzin screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica
AT compaoretegwinderebeca screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica
AT traorelassina screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica
AT nikiemajeanbaptiste screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica
AT pietravirginio screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica
AT zongojeandidier screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica
AT simporejacques screeningofhepatitisgandepsteinbarrvirusesamongvoluntarynonremuneratedblooddonorsvnrbdinburkinafasowestafrica